GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Haoyuan Chemexpress Co Ltd (SHSE:688131) » Definitions » Debt-to-Revenue

Shanghai Haoyuan Chemexpress Co (SHSE:688131) Debt-to-Revenue : 0.86 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Haoyuan Chemexpress Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Shanghai Haoyuan Chemexpress Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥805 Mil. Shanghai Haoyuan Chemexpress Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥1,291 Mil. Shanghai Haoyuan Chemexpress Co's annualized Revenue for the quarter that ended in Mar. 2025 was ¥2,425 Mil. Shanghai Haoyuan Chemexpress Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 was 0.86.


Shanghai Haoyuan Chemexpress Co Debt-to-Revenue Historical Data

The historical data trend for Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haoyuan Chemexpress Co Debt-to-Revenue Chart

Shanghai Haoyuan Chemexpress Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.20 0.48 0.56 0.84

Shanghai Haoyuan Chemexpress Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.51 0.57 0.73 0.86

Competitive Comparison of Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue falls into.


;
;

Shanghai Haoyuan Chemexpress Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(659.238 + 1246.665) / 2270.178
=0.84

Shanghai Haoyuan Chemexpress Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(805.101 + 1290.622) / 2424.5
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2025) Revenue data.


Shanghai Haoyuan Chemexpress Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Haoyuan Chemexpress Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haoyuan Chemexpress Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Lane 720, Cailun Road, Room 501, Pilot Free Trade Zone, Shanghai, CHN, 201203
Shanghai Haoyuan Chemexpress Co Ltd focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. The company's comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. It is a one-stop service platform to support client's projects from early drug discovery, process development to commercialization. The company is committed to delivering high-quality products and CMC services to clients across the entire life cycle of drug development.
Executives
Mei Kui Core technical personnel

Shanghai Haoyuan Chemexpress Co Headlines

No Headlines